Showing results (421-430 of 9,918) with videos related to

Sort By:
Pageof 992
Bone Marrow Transplantation|February 26, 2004
Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical resultsA I Benito, M A Diaz, M González-Vicent, et al.
Bone Marrow Transplantation|February 8, 2005
Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host diseaseU Banning, T Lange, R Krahl, et al.
Bone Marrow Transplantation|February 8, 2005
Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host diseaseJ Mayer, M Krejcí, M Doubek, et al.
Bone Marrow Transplantation|December 1, 1986
PUVA therapy for drug-resistant graft-versus-host diseaseK Atkinson, P Weller, W Ryman, et al.
Bone Marrow Transplantation|January 15, 2022
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Bone Marrow Transplantation|November 30, 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II studyRichard LeBlanc, Imran Ahmad, Rafik Terra, et al.
Bone Marrow Transplantation|December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMTTomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Bone Marrow Transplantation|December 5, 2021
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCTErik Boberg, Ellen Iacobaeus, Myrto Sklivanioti Greenfield, et al.
Bone Marrow Transplantation|September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.
Bone Marrow Transplantation|September 22, 2022
Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)Sung-Hoon Jung, Chang-Ki Min, Jae Hoon Lee, et al.
Pageof 992